Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine
The trial update reports on the association between DPYD gene variants and toxicity from capecitabine in breast cancer patients. Findings ma…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study [Phase 4]
Completed Phase 4 feasibility trial from Heidelberg University evaluating mistletoe extract in metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) [Phase 3]
This clinical trial update reports the completion of a Phase 3 study of MK0869 for the prevention of chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) [Phase 4]
Phase 4 clinical trial update for MK-0869-071 evaluating prevention of chemotherapy-induced nausea and vomiting; the study in breast cancer …
-
CLINICAL_TRIALS withdrawal · 2017-05-05Clinical Trial Update: Hybrid Gamma Camera in Breast Surgery
A clinical trial evaluating a hybrid gamma camera for breast cancer surgery has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk (SHAPE-2) [NA]
Clinical trial SHAPE-2 completed, comparing weight loss with and without exercise training to assess effects on breast cancer risk.
-
FDA approval · 2017-05-04FDA Approved: KISQALI FEMARA CO-PACK — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved the Kisqali Femara co-pack, combining ribociclib with letrozole for the treatment of hormone receptor-positive, HER2-negative b…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
Clinical trial update describing a study that uses high-throughput technologies to route metastatic breast cancer patients to specific Phase…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: AKT Inhibitor in Oestrogen Positive Breast Cancer [Phase 2]
A Phase 2 clinical trial of an AKT inhibitor for estrogen receptor-positive breast cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer [NA]
Completed clinical trial evaluating a videogame-based program for managing lymphedema in women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
An update on a completed clinical trial that seeks to define an exposure target for weekly paclitaxel infusion in breast cancer patients. Th…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer [Phase 2]
Phase 2 study of oral palbociclib (PD-0332991) as a single agent or with letrozole for first-line ER-positive, HER2-negative advanced breast…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery [Phase 2]
Phase 2 trial evaluating hypofractionated whole-breast irradiation with a simultaneously integrated boost after breast-conserving surgery fo…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial for breast cancer using doxorubicin, paclitaxel polyglutamate, capecitabine and metronomic chemotherapy was with…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Genexol-PM versus Genexol in recurrent or metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women [Phase 2]
Phase 2 clinical trial comparing fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone in premenopausal women …
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing maintenance versus observation after six cycles of gemcitabine plus paclitaxel in patients with advanced breast canc…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer
A completed clinical trial from Samsung Medical Center evaluated the usefulness of the Ki67 proliferation index in hormone receptor-positive…
-
CLINICAL_TRIALS research · 2017-05-01Clinical Trial Update: Prognostic Relevance of Biological Subtype in Breast Cancer
A clinical trial update from Samsung Medical Center evaluating how biological subtypes of breast cancer relate to prognosis.
-
CLINICAL_TRIALS research · 2017-05-01Clinical Trial Update: Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
A Samsung Medical Center trial investigates using tumor genome sequencing to guide molecular targeted therapy in refractory breast cancer an…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Exercise and Radiotherapy, a Good Combination? [NA]
A completed clinical trial explored whether adding structured exercise to radiotherapy is beneficial for breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care [NA]
This ClinicalTrials.gov study evaluates health information technology–enabled family history documentation and management in primary care. T…
-
FDA approval · 2017-04-27FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech, Inc. The action pertains to a supplemental appro…
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer [Phase 3]
Phase 3 trial update of Herceptin (trastuzumab) in HER2-positive primary breast cancer; results were posted.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Imaging Modality Effects on the Multi-dimensional InfraRed Analysis (MIRA) Technology
A clinical trial evaluating the MIRA imaging technology for breast cancer has been withdrawn.